首页> 美国卫生研究院文献>The Open Cardiovascular Medicine Journal >The Current Indication for Pacemaker in Patients with Cardioinhibitory Vasovagal Syncope
【2h】

The Current Indication for Pacemaker in Patients with Cardioinhibitory Vasovagal Syncope

机译:心脏抑制性血管迷走性晕厥患者起搏器的当前适应症

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The most frequent cause of syncope is vasovagal reflex. It is associated with worse quality of life, depression, fatigue and physical injury. Recurrence of vasovagal syncope is an aggravating, reaching the rate of 69%. Initial step and pharmacological treatment may not work, especially in patients with recurrent syncope without prodrome. These patients can present cardioinhibitory response with asystole. Studies were designed to analyses the effectiveness of pacemaker for prevention of syncope. In this review, nonrandomized clinical trials, open-label randomized, double-blind randomized, placebo-controlled, and studies based on tilt test or Implantable Loop Recorder findings will be discussed.
机译:晕厥的最常见原因是血管迷走神经反射。它与生活质量下降,抑郁,疲劳和身体伤害有关。血管迷走性晕厥的复发加剧,达到69%的比率。最初的步骤和药物治疗可能无效,尤其是在患有晕厥而无前驱的患者中。这些患者可表现出心搏停止的心脏抑制反应。设计研究旨在分析起搏器预防晕厥的有效性。在这篇综述中,将讨论非随机临床试验,开放标签随机,双盲随机,安慰剂对照以及基于倾斜试验或可植入Loop Recorder研究结果的研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号